Our study depicts a comprehensive landscape of alternative splicing events in GC and identified that SASEs can be used to predict overall survival of GC patients, and found ECT2 might be a biomarker for diagnosis and prognosis. The gene discussed is ECT2; the disease is gastric cancer.